Aider is a “pair-programming” tool that can use various providers as the AI back end, including a locally running instance of ...

An exercise-driven course on Advanced Python Programming that was battle-tested several hundred times on the corporate-training circuit for more than a decade. Written by David Beazley, author of the ...

Found this to be true across different models: The agent starts a python REPL to inspect some object. For any subsequent commands they automatically enter the REPL and try to execute terminal commands ...

Replimune Group announced that the U.S. Food and Drug Administration has accepted the resubmission of its Biologics License Application for RP1 in combination with nivolumab, targeting advanced ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

Simply sign up to the Artificial intelligence myFT Digest -- delivered directly to your inbox. Ten lossmaking artificial intelligence start-ups have gained close to $1tn in valuation over the past 12 ...

Bill Belichick is a football savant who might know more about X’s and O’s than any coach who ever lived. But there’s one thing his encyclopedic knowledge of professional football didn’t prepare him ...

The latest trends and issues around the use of open source software in the enterprise. JetBrains has detailed its eighth annual Python Developers Survey. This survey is conducted as a collaborative ...

NEW YORK--(BUSINESS WIRE)--Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Replimune Group, Inc. (NASDAQ: REPL) for potential violations of the federal ...

Replimune (NASDAQ:REPL) announced on Tuesday that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter regarding its marketing application for its lead asset, RP1, declining ...